Northern Trust’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
Other funds holding JUNO
Northern Trust's JUNO Position: Q1 2018 in Review
Northern Trust sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 427,121 shares — an estimated $19.5M sold.
Northern Trust first reported a position in JUNO in Q1 2015 and held it in 12 quarters. The position peaked at $19.5M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.
- Northern Trust reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
- Northern Trust sold 427,121 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $19.5M.
- Northern Trust first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 12 quarters.
- Northern Trust's Juno Therapeutics, Inc. position peaked at $19.5M in Q4 2017.
- 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.
Based on Northern Trust's 13F filing for Q1 2018, filed 9 May 2018.